The three glucose-lowering medications are common second-line therapies recommended by the guidelines [8, 9]
Major biopharmaceutical companies, including Novo Nordisk, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Eccogene, AstraZeneca, and others, are driving innovation in the GLP-1 agonists space through robust pipelines, strategic collaborations, and the development of next-generation treatments targeting diabetes, obesity, and related metabolic disorders
"Ozempic hair loss" has become a trending topic, but the medical reality behind it is much more nuanced than a simple drug reaction
Moringa's Anti-Obesity Mechanisms A systematic review in ScienceDirect that analyzed 36 research articles across in-vitro, in-vivo, and clinical studies mapped out moringa's metabolic toolkit in detail
All research activities should follow applicable laboratory safety standards and institutional guidelines
Acromegaloid features, including jaw growth, soft-tissue swelling, and peripheral nerve entrapment, are described after sustained supraphysiologic exposure [1]
